Ligand profile
ZINC6117582
Virtual-screening candidate from ZINC.
Bound to: KP13_03396 — 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC6117582- UniProt (similar protein)
G5EGA6- Tanimoto
- 0.667
- Target protein
- KP13_03396
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 58.2
- −1 ≤ LogP ≤ 5 2.50
- MW ≤ 500 Da 262.3
- LogP ≤ 5 2.50
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 0
- TPSA ≤ 140 Ų 58.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C1Nc2ccccc2C1=C1C(=O)Nc2ccccc21O=C1Nc2ccccc2C1=C1C(=O)Nc2ccccc21
InChI=1S/C16H10N2O2/c19-15-13(9-5-1-3-7-11(9)17-15)14-10-6-2-4-8-12(10)18-16(14)20/h1-8H,(H,17,19)(H,18,20)InChI=1S/C16H10N2O2/c19-15-13(9-5-1-3-7-11(9)17-15)14-10-6-2-4-8-12(10)18-16(14)20/h1-8H,(H,17,19)(H,18,20)
MLCPSWPIYHDOKG-UHFFFAOYSA-NMLCPSWPIYHDOKG-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- ISN
- Homolog
- G5EGA6
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC6117582 →
- ZINC ZINC20 ZINC6117582 →
- UniProt UniProt G5EGA6 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC6117582”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03396.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).